Adding Tislelizumab to Chemo Slows Advanced Nasopharyngeal Cancer

Progression - free survival prolonged with tislelizumab + chemotherapy versus chemotherapy alone in recurrent/metastatic NPC
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, ENT, Pharmacy, Conference News, Source Type: news